Immutep (IMMP) Enterprise Value Growth (1y) (2012 - 2025)
Immutep (IMMP) Enterprise Value Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.51% |
| Jun 30, 2025 | 22.10% |
| Dec 31, 2024 | -54.23% |
| Jun 30, 2024 | -29.26% |
| Dec 31, 2023 | -50.32% |
| Jun 30, 2023 | -43.96% |
| Dec 31, 2022 | 38.12% |
| Jun 30, 2022 | -22.80% |
| Dec 31, 2021 | -80.98% |
| Jun 30, 2021 | -170.46% |
| Dec 31, 2020 | -186.19% |
| Jun 30, 2020 | -48.65% |
| Dec 31, 2019 | 24.86% |
| Jun 30, 2019 | 34.70% |
| Jun 30, 2018 | -93.33% |
| Jun 30, 2017 | 41.04% |
| Jun 30, 2016 | -196.68% |
| Jun 30, 2015 | 60.31% |
| Jun 30, 2014 | 55.60% |
| Jun 30, 2013 | 22.40% |